Simple Summary Small cell lung cancer (SCLC) accounts for about 15% of lung cancers and
it has limited therapeutic options and poor prognosis. There has been no real progress for …

Simple Summary Non-small cell lung cancer (NSCLC) remains a significant cause of death
worldwide, despite the significant progresses to date. Multiple molecular alterations have …

Inhibition of angiogenesis has been demonstrated to be an efficacious strategy in treating
several tumors. Vascular endothelial growth factor (VEGF) is the most important protein with …

Background Uniportal video-assisted thoracic surgery (VATS) technique has been described
both for diagnostic and therapeutic indications. Outcomes after uniportal VATS have never …

PURPOSE: Traditional 3-port video-assisted thoracoscopic surgery (VATS) in a patient who
is awake has been proposed as a breakthrough in the direction of fast tracking patients …

Objectives: Flexible bronchoscopy is recommended to confirm correct placement of double-lumen
tubes used for thoracic anesthesia. However, there is still controversy over routine …

Patients with small-cell-lung cancer (SCLC) in progression after a first line therapy have few
treatment options. A novel therapeutic approach is represented by lurbinectedin, a synthetic …

Simple Summary Small-cell lung cancer (SCLC) accounts for approximately 15% of all lung
cancers and is one of the most aggressive tumors, with poor prognosis and limited …

The objective of the present study was to assess feasibility of single port (uniportal) VATS in
the diagnosis and staging of mediastinal nodal enlargements. To this purpose, between …

Immune checkpoint inhibitors against programmed cell death protein 1/programmed death-ligand
1 (PD-L1) have proven to be remarkably effective in non–small cell lung cancer. PD-…